Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 6
2009 4
2010 10
2011 5
2012 5
2013 17
2014 12
2015 13
2016 10
2017 4
2018 2
2019 3
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018.
Velati C, Romanò L, Pati I, Marano G, Piccinini V, Catalano L, Pupella S, Vaglio S, Veropalumbo E, Masiello F, Pisani G, Grazzini G, Zanetti A, Liumbruno GM. Velati C, et al. Among authors: grazzini g. Blood Transfus. 2019 Nov;17(6):409-417. doi: 10.2450/2019.0245-19. Epub 2019 Dec 11. Blood Transfus. 2019. PMID: 31846606 Free PMC article.
Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
Franchini M, Forni GL, Marano G, Cruciani M, Mengoli C, Pinto V, De Franceschi L, Venturelli D, Casale M, Amerini M, Capuzzo M, Grazzini G, Masiello F, Pati I, Veropalumbo E, Vaglio S, Pupella S, Liumbruno GM. Franchini M, et al. Among authors: grazzini g. Blood Transfus. 2019 Jan;17(1):4-15. doi: 10.2450/2019.0229-18. Blood Transfus. 2019. PMID: 30653458 Free PMC article.
Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey.
Velati C, Romanò L, Piccinini V, Marano G, Catalano L, Pupella S, Facco G, Pati I, Tosti ME, Vaglio S, Grazzini G, Zanetti A, Liumbruno GM. Velati C, et al. Among authors: grazzini g. Blood Transfus. 2018 Sep;16(5):422-432. doi: 10.2450/2018.0069-18. Epub 2018 Jun 26. Blood Transfus. 2018. PMID: 30036178 Free PMC article.
Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies.
Rebulla P, Vaglio S, Beccaria F, Bonfichi M, Carella A, Chiurazzi F, Coluzzi S, Cortelezzi A, Gandini G, Girelli G, Graf M, Isernia P, Marano G, Marconi M, Montemezzi R, Olivero B, Rinaldi M, Salvaneschi L, Scarpato N, Strada P, Milani S, Grazzini G. Rebulla P, et al. Among authors: grazzini g. Transfusion. 2017 May;57(5):1171-1183. doi: 10.1111/trf.14042. Epub 2017 Feb 24. Transfusion. 2017. PMID: 28236335 Clinical Trial.
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.
Cicchetti A, Berrino A, Casini M, Codella P, Facco G, Fiore A, Marano G, Marchetti M, Midolo E, Minacori R, Refolo P, Romano F, Ruggeri M, Sacchini D, Spagnolo AG, Urbina I, Vaglio S, Grazzini G, Liumbruno GM. Cicchetti A, et al. Among authors: grazzini g. Blood Transfus. 2016 Jul;14(4):287-386. doi: 10.2450/2016.0065-16. Blood Transfus. 2016. PMID: 27403740 Free PMC article. Review.
77 results